Huang Guo, Deputy Director of the National Medical Products Administration, embarked on a research tour to Shanghai and Jiangsu, underscoring the pivotal role of digitalization and intelligence in advancing the pharmaceutical sector. He championed the integration of AI in drug research and development, as well as intelligent manufacturing, aiming to elevate the informational sophistication across the entire pharmaceutical supply chain. Additionally, Huang Guo urged the Yangtze River Delta Sub-center for Drugs to enhance its innovative service framework, thereby fostering the high-quality growth of the industry.